Correction: KRAS Inhibitor Resistance in MET-Amplified KRASG12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms
In the original version of this article (1), the “Crizotinib” label in Fig. 4F is incorrect; the label should be “Selumetinib”. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets the error.
©2022 American Association for Cancer Research
Comments (0)